SCHEMBL1002192

SCHEMBL1002192

CCOCC(Oc1ccc(F)cc1)N1CCCC1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.44
HTR6 P50406 2/20 0.44
HTR1A P08908 1/20 0.44
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
LTA4H P09960 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
HRH3 Q9Y5N1 2/20 0.35
ALDH1A1 P00352 1/20 0.35
SLC6A4 P31645 1/20 0.35
ACHE P22303 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1002190 1.00 HTR7 (0.44) HTR7HTR6HTR1ASLC6A2SLC6A3
SCHEMBL1002277 0.85 HTR7 (0.42) HTR7HTR6HTR1ALTA4HLMNA
SCHEMBL1002275 0.85 HTR7 (0.42) HTR7HTR6HTR1ALTA4HLMNA
SCHEMBL996214 0.85 SLC6A4 (0.42) HTR7HTR6HTR1ASLC6A2SLC6A3
SCHEMBL996213 0.85 SLC6A4 (0.42) HTR7HTR6HTR1ASLC6A2SLC6A3
SCHEMBL994382 0.79 SLC6A2 (0.45) SLC6A2SLC6A3LTA4HMEN1LMNA
SCHEMBL8645197 0.78 HTR7 (0.48) HTR7HTR6HTR1ASLC6A2SLC6A3
SCHEMBL8645200 0.78 HTR7 (0.48) HTR7HTR6HTR1ASLC6A2SLC6A3
SCHEMBL996959 0.76 HTR7 (0.47) HTR7HTR6HTR1ASLC6A2MEN1
SCHEMBL996958 0.76 HTR7 (0.47) HTR7HTR6HTR1ASLC6A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2456436-A1 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS Theravance, Inc. (US) 2012-05-30 EP disclosed
WO-2011011231-A1 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS THERAVANCE, INC. (US) 2011-01-27 WO disclosed